Stockhouse Ticker Trax is published to subscribers every Monday (annual cost only $195). We focus on best-in-class high growth small companies trading on the TSX and TSX.V between 5 cents and $3 with a market cap below $300 million.
Equity Analyst Danny Deadlock has 30 years of experience speculating on Canadian penny stocks and targets capital gain opportunities and diversification in metals and minerals exploration, energy, and technology.
For the experienced investor, Ticker Trax provides an extra set of eyes and ears (idea generation) and for those learning to invest in micro cap stocks, we provide stock picks and market education.
Subscribers receive; (1) new research (stock picks) weeks in advance of being featured on this weekend column (2) exclusive access to our list of junior gold exploration companies (critical for peer valuation), (3) exclusive access to our list of Cash Rich micro cap companies (our Virtual Vulture Fund) which contains 80 companies with almost $3 Billion.
Both tables are updated monthly.
Vivione Biosciences (TSX: V.VBI, Stock Forum) (30 cents)
www.vivionebiosciences.com
- Shares Outstanding: Approx. 66 million / Market Cap $20 Million
- VBI went public in April 2013 after raising $6 million.
- Target is a > $100 Million valuation by 2016
- Portfolio Diversification through biosciences
- A company unique within their industry commercializing a world leading technology
VBI first caught my attention late April following a very positive news release associated with the USDA Food Safety and Inspection division - but on further research I discovered that VBI’s technology originates from research & development “with” the FDA in the United States and is the culmination of 7 years of work.
Most companies develop a product and then seek FDA approval - in this case the FDA and partners identified a serious need and the technology was developed to address that need - it is now entering the business cycle where we find out if it will become a commercial success.
Given the stellar reputation of the FDA (globally) I have to believe that this will be very well accepted by their target markets.
_____________________________________________
My complete 7 page report is too large to display in this weekend column so it is available on a separate page HERE.
_____________________________________________
** TWITTER NOTE: I maintain a twitter page at - twitter.com/tsxalerts